{"id":"NCT00112294","sponsor":"Eli Lilly and Company","briefTitle":"Study of Taxane/Carboplatin +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer","officialTitle":"A Randomized Multicenter Phase III Study of Taxane/Carboplatin/Cetuximab Versus Taxane/Carboplatin as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2004-12","primaryCompletion":"2007-04","completion":"2008-08","firstPosted":"2005-06-02","resultsPosted":"2010-10-05","lastUpdate":"2015-12-24"},"enrollment":755,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Non-Small-Cell Lung Carcinoma"],"interventions":[{"type":"DRUG","name":"Paclitaxel (Taxane)","otherNames":[]},{"type":"DRUG","name":"Docetaxel (Taxane)","otherNames":[]},{"type":"DRUG","name":"Carboplatin","otherNames":[]},{"type":"DRUG","name":"Cetuximab","otherNames":["Erbitux"]}],"arms":[{"label":"Cetuximab+Taxane+Carboplatin (C/T/C)","type":"ACTIVE_COMPARATOR"},{"label":"Taxane+Carboplatin (T/C)","type":"ACTIVE_COMPARATOR"}],"summary":"The primary purpose of this clinical research study is to learn if patients treated with the combination of Taxane/Carboplatin plus Cetuximab (C/T/C) have a longer progression-free survival than patients treated with Taxane/Carboplatin (T/C) alone. The safety of this treatment will also be studied.","primaryOutcome":{"measure":"Median Number of Months of Progression-free Survival (PFS)","timeFrame":"From randomization to evidence of disease progression/death or date of last tumor assessment (up to 26 months).","effectByArm":[{"arm":"Cetuximab+Taxane+Carboplatin (C/T/C)","deltaMin":4.4,"sd":null},{"arm":"Taxane+Carboplatin (T/C)","deltaMin":4.24,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.2358"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":14},"locations":{"siteCount":124,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":183,"n":325},"commonTop":["Fatigue","Nausea","Diarrhoea","Alopecia","Constipation"]}}